We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNTX icon
76
Gentex
GNTX
$5.02B
$401K 0.46%
15,573
+7,344
+89% +$184K
GBCI icon
77
Glacier Bancorp
GBCI
$6.35B
$400K 0.46%
11,344
+6,581
+138% +$244K
LDOS icon
78
Leidos
LDOS
$17.5B
$395K 0.45%
+4,215
New +$415K
WSM icon
79
Williams-Sonoma
WSM
$29.5B
$390K 0.45%
9,508
-5,784
-38% -$197K
DOW icon
80
Dow Inc
DOW
$22.1B
$384K 0.44%
+9,423
New +$345K
MAN icon
81
ManpowerGroup
MAN
$2.63B
$381K 0.44%
5,546
-375
-6% -$25.6K
SGEN
82
DELISTED
Seagen Inc. Common Stock
SGEN
$380K 0.44%
2,239
+1,099
+96% +$164K
RGA icon
83
Reinsurance Group of America
RGA
$15.8B
$375K 0.43%
4,780
+3,553
+290% +$328K
SSNC icon
84
SS&C Technologies
SSNC
$18.7B
$368K 0.42%
6,512
+4,205
+182% +$229K
KEYS icon
85
Keysight
KEYS
$57.3B
$364K 0.42%
3,611
+1,520
+73% +$149K
ZBH icon
86
Zimmer Biomet
ZBH
$18.7B
$360K 0.41%
+3,106
New +$358K
ARW icon
87
Arrow Electronics
ARW
$10.3B
$359K 0.41%
5,229
+1,017
+24% +$64.2K
KSU
88
DELISTED
Kansas City Southern
KSU
$358K 0.41%
2,401
+1,910
+389% +$269K
COF icon
89
Capital One
COF
$134B
$356K 0.41%
5,682
-4,072
-42% -$254K
AOS icon
90
A.O. Smith
AOS
$8.48B
$352K 0.4%
7,463
+6,831
+1,081% +$298K
ETFC
91
DELISTED
E*Trade Financial Corporation
ETFC
$352K 0.4%
7,084
+3,598
+103% +$155K
TRI icon
92
Thomson Reuters
TRI
$45.2B
$351K 0.4%
+4,903
New +$355K
AON icon
93
Aon
AON
$75.7B
$345K 0.4%
+1,789
New +$333K
CBOE icon
94
Cboe Global Markets
CBOE
$29.8B
$345K 0.4%
3,700
+2,854
+337% +$281K
XYL icon
95
Xylem
XYL
$28.3B
$339K 0.39%
5,218
+2,333
+81% +$154K
OPTU
96
Optimum Communications Inc
OPTU
$306M
$330K 0.38%
14,662
+12,685
+642% +$311K
GPN icon
97
Global Payments
GPN
$22.8B
$325K 0.37%
1,918
+955
+99% +$159K
THO icon
98
Thor Industries
THO
$4.14B
$321K 0.37%
+3,016
New +$236K
CHRW icon
99
C.H. Robinson
CHRW
$17.3B
$318K 0.36%
4,026
+4,025
+402,500% +$304K
AAPL icon
100
Apple
AAPL
$4.5T
$310K 0.36%
3,396
+1,156
+52% +$89.6K
2 3
4
5 6

Similar funds

KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
ACA
Anchorage Capital Advisors New York $378M AUM 13.47% 1-Year Est. Return
AFCM
Alta Fox Capital Management Fort Worth, Texas $378M AUM 59.19% 1-Year Est. Return
DAL
Delta Air Lines Atlanta, Georgia $378M AUM 12.68% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
WAM
Wakefield Asset Management Englewood, Colorado $377M AUM 38.72% 1-Year Est. Return
FP
Fivespan Partners San Francisco, California $377M AUM

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.